Rocket Lab (RKLB): Does Strong Contract Momentum Justify Today's Valuation After Latest Japanese Wins?

Rocket Lab, a leading aerospace company, has attracted attention after securing several major contracts with Japanese partners, including iQPS, Synspective, and the Japan Aerospace Exploration Agency (JAXA). These deals highlight the firm’s expanding role in global launch services and government space efforts.

See our latest analysis for Rocket Lab.

Rocket Lab’s string of major contract wins has generated intense buzz and helped fuel remarkable momentum in its shares. After a stellar run, bolstered by deals with Synspective, iQPS, and JAXA, the company has notched a 1-year total shareholder return of over 560%, vastly outpacing the broader market. Recent launches and rapid-fire contract announcements have reinforced Rocket Lab’s reputation as a leader in commercial small-lift, with short-term share price gains adding to the optimism surrounding its expanding launch roster and robust order pipeline.

If recent contract news has you looking for more companies reshaping the space industry, check out the latest opportunities with See the full list for free.

But after such a dramatic run-up and a wave of contract announcements, the big question for investors now is whether Rocket Lab’s fundamentals can keep pace with its share price, or if the market has already priced in all the future growth.

Most Popular Narrative: 34% Overvalued

Rocket Lab's narrative fair value sits at $48.09, which is notably below the last close price of $64.26. This gap sets up a debate over whether the company’s rapid progress justifies such a rich valuation, especially in light of what analysts see as its next phase of growth.

Rocket Lab's move toward end-to-end space solutions, including the acquisition of Geost and expanding vertically integrated payload, satellite, and launch service capabilities, uniquely positions the company to capture larger, national security and defense contracts like the Golden Dome and SDA constellations. This supports significant top-line growth and enhanced gross margins in future quarters.

Read the complete narrative.

Want to know why so many are watching this stock? The key to this bold price target is a roadmap packed with ambitious revenue forecasts and profit margin shifts. Curious how the experts think Rocket Lab can deliver breakthrough results and outgrow sector norms? Unlock the full story inside the narrative.

Result: Fair Value of $48.09 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, execution risks remain, including the need for successful Neutron rocket launches as well as potential delays or technical setbacks that could dampen near-term momentum.

Find out about the key risks to this Rocket Lab narrative.

Build Your Own Rocket Lab Narrative

If you see the story differently, or want to dive deeper into the numbers yourself, you can craft a personal narrative in just a few minutes: Do it your way

A great starting point for your Rocket Lab research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Don’t wait until the market has moved. Give yourself an edge and get ahead of the next wave by checking out these handpicked stock ideas today.

• Position yourself for the next tech revolution by checking out these 24 AI penny stocks, which are poised for explosive growth as artificial intelligence adoption surges globally.
• Secure your portfolio with steady income possibilities by reviewing these 19 dividend stocks with yields > 3%, offering yields above 3% and a track record of reliable payouts.
• Tap into fast-moving companies trading below intrinsic worth by seizing opportunities among these 892 undervalued stocks based on cash flows and riding the upside before the crowd.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com